Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058287 · ClinicalTrials.gov registry record · Phase 3
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
A Phase 3 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05058287: Recruiting Phase 3 study of Pain, Postoperative and Opioid Use, sponsored by Hospital for Special Surgery, New York.
NCT05058287 is a Phase 3 study of Pain, Postoperative and Opioid Use that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 150 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05058287, a Phase 3 study of Pain, Postoperative and Opioid Use, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
Primary Outcome
Number \& dose of opioid taken converted to oral morphine equivalents post-operatively in hospital
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Depo-Medrol 40Mg/Ml Suspension for Injection
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 3 |
What NCT05058287 shows while recruiting
NCT05058287 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (45% lower).
The record links to 4 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05058287 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05058287 about?
NCT05058287 is a clinical study titled "Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression". This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
What is the current status of trial NCT05058287?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2021-11-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05058287 study?
This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Lumbar Spinal Stenosis, Pain, Back.
What interventions are being tested in trial NCT05058287?
The interventions under investigation include: Placebo (DRUG), Depo-Medrol 40Mg/Ml Suspension for Injection (DRUG).
Who is sponsoring clinical trial NCT05058287?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05058287 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05058287's enrollment target sits among peer trials
150 25th of 113 higher than 89 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
-
Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI